CMMB Q1 2019 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q1 2019 Earnings

Revenue

Gross Profit

Operating Income

-$5M

Net Income

-$19M

EPS (Diluted)

$-30.23

QoQ Revenue Growth

NaN%

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$12,711	+100.0%
Operating Income	-$5M	-$3M	-59.9%
Net Income	-$19M	-$4M	-421.7%